{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:02:53Z","timestamp":1777507373617,"version":"3.51.4"},"reference-count":44,"publisher":"Japanese Circulation Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1253\/circj.cj-17-0394","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T22:13:45Z","timestamp":1498601625000},"page":"1862-1870","source":"Crossref","is-referenced-by-count":10,"title":["Differential Effects of Myocardial Afadin on Pressure Overload-Induced Compensated Cardiac Hypertrophy"],"prefix":"10.1253","volume":"81","author":[{"given":"Dimitar P.","family":"Zankov","sequence":"first","affiliation":[{"name":"Division of Molecular Medical Biochemistry, Department of Biochemistry and Molecular Biology, Shiga University of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Molecular Medical Biochemistry, Department of Biochemistry and Molecular Biology, Shiga University of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Division of Molecular Medical Biochemistry, Department of Biochemistry and Molecular Biology, Shiga University of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisakazu","family":"Ogita","sequence":"additional","affiliation":[{"name":"Division of Molecular Medical Biochemistry, Department of Biochemistry and Molecular Biology, Shiga University of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Burchfield JS, Xie M, Hill JA. Pathological ventricular remodeling: Mechanisms: Part 1 of 2. <i>Circulation<\/i> 2013; 128: 388\u2013400.","DOI":"10.1161\/CIRCULATIONAHA.113.001878"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Xie M, Burchfield JS, Hill JA. Pathological ventricular remodeling: Therapies: Part 2 of 2. <i>Circulation<\/i> 2013; 128: 1021\u20131030.","DOI":"10.1161\/CIRCULATIONAHA.113.001879"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. <i>Nat Rev Cardiol<\/i> 2016; 13: 368\u2013378.","DOI":"10.1038\/nrcardio.2016.25"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Rahimi K, Emdin CA, MacMahon S. The epidemiology of blood pressure and its worldwide management. <i>Circ Res<\/i> 2015; 116: 925\u2013936.","DOI":"10.1161\/CIRCRESAHA.116.304723"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Baker KM, Booz GW, Dostal DE. Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system. <i>Annu Rev Physiol<\/i> 1992; 54: 227\u2013241.","DOI":"10.1146\/annurev.ph.54.030192.001303"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Xu J, Carretero OA, Liao TD, Peng H, Shesely EG, Xu J, et al. Local angiotensin II aggravates cardiac remodeling in hypertension. <i>Am J Physiol Heart Circ Physiol<\/i> 2010; 299: H1328\u2013H1338.","DOI":"10.1152\/ajpheart.00538.2010"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: Critical role of the AT1 receptor subtype. <i>Circ Res<\/i> 1993; 73: 413\u2013423.","DOI":"10.1161\/01.RES.73.3.413"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. <i>Pharmacol Rev<\/i> 2000; 52: 11\u201334.","DOI":"10.1016\/S0031-6997(24)01434-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Atlas SA. The renin-angiotensin aldosterone system: Pathophysiological role and pharmacologic inhibition. <i>J Manag Care Pharm<\/i> 2007; 13: 9\u201320.","DOI":"10.18553\/jmcp.2007.13.s8-b.9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Dostal DE, Baker KM. Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart: Mediation by the AT1 receptor. <i>Am J Hypertens<\/i> 1992; 5: 276\u2013280.","DOI":"10.1093\/ajh\/5.5.276"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yasuda N, Miura S, Akazawa H, Tanaka T, Qin Y, Kiya Y, et al. Conformational switch of angiotensin II type 1 receptor underlying mechanical stress-induced activation. <i>EMBO Rep<\/i> 2008; 9: 179\u2013186.","DOI":"10.1038\/sj.embor.7401157"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Zou Y, Akazawa H, Qin Y, Sano M, Takano H, Minamino T, et al. Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. <i>Nat Cell Biol<\/i> 2004; 6: 499\u2013506.","DOI":"10.1038\/ncb1137"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ogita H, Rikitake Y, Miyoshi J, Takai Y. Cell adhesion molecules nectins and associating proteins: Implications for physiology and pathology. <i>Proc Jpn Acad Ser B Phys Biol Sci<\/i> 2010; 86: 621\u2013629.","DOI":"10.2183\/pjab.86.621"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Takai Y, Nakanishi H. Nectin and afadin: Novel organizers of intercellular junctions. <i>J Cell Sci<\/i> 2003; 116: 17\u201327.","DOI":"10.1242\/jcs.00167"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Elloul S, Kedrin D, Knoblauch NW, Beck AH, Toker A. The adherens junction protein afadin is an AKT substrate that regulates breast cancer cell migration. <i>Mol Cancer Res<\/i> 2014; 12: 464\u2013476.","DOI":"10.1158\/1541-7786.MCR-13-0398"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ikeda W, Nakanishi H, Miyoshi J, Mandai K, Ishizaki H, Tanaka M, et al. Afadin: A key molecule essential for structural organization of cell-cell junctions of polarized epithelia during embryogenesis. <i>J Cell Biol<\/i> 1999; 146: 1117\u20131132.","DOI":"10.1083\/jcb.146.5.1117"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Miyata M, Ogita H, Komura H, Nakata S, Okamoto R, Ozaki M, et al. Localization of nectin-free afadin at the leading edge and its involvement in directional cell movement induced by platelet-derived growth factor. <i>J Cell Sci<\/i> 2009; 122: 4319\u20134329.","DOI":"10.1242\/jcs.048439"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Zankov DP, Shimizu A, Tanaka-Okamoto M, Miyoshi J, Ogita H. Protective effects of intercalated disk protein afadin on chronic pressure overload-induced myocardial damage. <i>Sci Rep<\/i> 2017; 7: 39335, doi:10.1038\/srep39335.","DOI":"10.1038\/srep39335"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Majima T, Ogita H, Yamada T, Amano H, Togashi H, Sakisaka T, et al. Involvement of afadin in the formation and remodeling of synapses in the hippocampus. <i>Biochem Biophys Res Commun<\/i> 2009; 385: 539\u2013544.","DOI":"10.1016\/j.bbrc.2009.05.097"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Satoh M, Ogita H, Takeshita K, Mukai Y, Kwiatkowski DJ, Liao JK. Requirement of Rac1 in the development of cardiac hypertrophy. <i>Proc Natl Acad Sci USA<\/i> 2006; 103: 7432\u20137437.","DOI":"10.1073\/pnas.0510444103"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Collins KA, Korcarz CE, Lang RM. Use of echocardiography for the phenotypic assessment of genetically altered mice. <i>Physiol Genomics<\/i> 2003; 13: 227\u2013239.","DOI":"10.1152\/physiolgenomics.00005.2003"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Liao Y, Ishikura F, Beppu S, Asakura M, Takashima S, Asanuma H, et al. Echocardiographic assessment of LV hypertrophy and function in aortic-banded mice: necropsy validation. <i>Am J Physiol Heart Circ Physiol<\/i> 2002; 282: H1703\u2013H1708.","DOI":"10.1152\/ajpheart.00238.2001"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Hartley CJ, Taffet GE, Reddy AK, Entman ML, Michael LH. Noninvasive cardiovascular phenotyping in mice. <i>ILAR J<\/i> 2002; 43: 147\u2013158.","DOI":"10.1093\/ilar.43.3.147"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Qui\u00f1ones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA, Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. <i>J Am Soc Echocardiogr<\/i> 2002; 15: 167\u2013184.","DOI":"10.1067\/mje.2002.120202"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: An open-source platform for biological-image analysis. <i>Nat Methods<\/i> 2012; 9: 676\u2013682.","DOI":"10.1038\/nmeth.2019"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Bell RM, Mocanu MM, Yellon DM. Retrograde heart perfusion: The Langendorff technique of isolated heart perfusion. <i>J Mol Cell Cardiol<\/i> 2011; 50: 940\u2013950.","DOI":"10.1016\/j.yjmcc.2011.02.018"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Li YH, Reddy AK, Taffet GE, Michael LH, Entman ML, Hartley CJ. Doppler evaluation of peripheral vascular adaptations to transverse aortic banding in mice. <i>Ultrasound Med Biol<\/i> 2003; 29: 1281\u20131289.","DOI":"10.1016\/S0301-5629(03)00986-4"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kawada N, Imai E, Karber A, Welch WJ, Wilcox CS. A mouse model of angiotensin II slow pressor response: Role of oxidative stress. <i>J Am Soc Nephrol<\/i> 2002; 13: 2860\u20132868.","DOI":"10.1097\/01.ASN.0000035087.11758.ED"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Guo X, Chapman D, Dhalla NS. Partial prevention of changes in SR gene expression in congestive heart failure due to myocardial infarction by enalapril or losartan. <i>Mol Cell Biochem<\/i> 2003; 254: 163\u2013172.","DOI":"10.1023\/A:1027321130997"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Piek A, de Boer RA, Sillj\u00e9 HH. The fibrosis-cell death axis in heart failure. <i>Heart Fail Rev<\/i> 2016; 21: 199\u2013211.","DOI":"10.1007\/s10741-016-9536-9"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Wencker D, Chandra M, Nguyen K, Miao W, Garantziotis S, Factor SM, et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. <i>J Clin Invest<\/i> 2003; 111: 1497\u20131504.","DOI":"10.1172\/JCI17664"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Jin Z, El-Deiry WS. Overview of cell death signaling pathways. <i>Cancer Biol Ther<\/i> 2005; 4: 139\u2013163.","DOI":"10.4161\/cbt.4.2.1508"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Wolf BB, Schuler M, Echeverri F, Green DR. Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45\/inhibitor of caspase-activated DNase inactivation. <i>J Biol Chem<\/i> 1999; 274: 30651\u201330656.","DOI":"10.1074\/jbc.274.43.30651"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Kempf T, von Haehling S, Peter T, Allhoff T, Cicoira M, Doehner W, et al. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. <i>J Am Coll Cardiol<\/i> 2007; 50: 1054\u20131060.","DOI":"10.1016\/j.jacc.2007.04.091"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Liquori ME, Christenson RH, Collinson PO, Defilippi CR. Cardiac biomarkers in heart failure. <i>Clin Biochem<\/i> 2014; 47: 327\u2013337.","DOI":"10.1016\/j.clinbiochem.2014.01.032"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Baek SJ, Kim KS, Nixon JB, Wilson LC, Eling TE. Cyclooxygenase inhibitors regulate the expression of a TGF-\u03b2 superfamily member that has proapoptotic and antitumorigenic activities. <i>Mol Pharmacol<\/i> 2001; 59: 901\u2013908.","DOI":"10.1124\/mol.59.4.901"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Kang SU, Shin YS, Hwang HS, Baek SJ, Lee SH, Kim CH. Tolfenamic acid induces apoptosis and growth inhibition in head and neck cancer: Involvement of NAG-1 expression. <i>PLoS One<\/i> 2012; 7: e34988.","DOI":"10.1371\/journal.pone.0034988"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Jia L, Li Y, Xiao C, Du J. Angiotensin II induces inflammation leading to cardiac remodeling. <i>Front Biosci<\/i> 2012; 17: 221\u2013231.","DOI":"10.2741\/3923"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Ainscough JF, Drinkhill MJ, Sedo A, Turner NA, Brooke DA, Balmforth AJ, et al. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction. <i>Cardiovasc Res<\/i> 2009; 81: 592\u2013600.","DOI":"10.1093\/cvr\/cvn230"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Miura S, Saku K, Karnik SS. Molecular analysis of the structure and function of the angiotensin II type 1 receptor. <i>Hypertens Res<\/i> 2003; 26: 937\u2013943.","DOI":"10.1291\/hypres.26.937"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Kenakin T. Ligand-selective receptor conformations revisited: The promise and the problem. <i>Trends Pharmacol Sci<\/i> 2003; 24: 346\u2013354.","DOI":"10.1016\/S0165-6147(03)00167-6"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Byrne JA, Grieve DJ, Bendall JK, Li JM, Gove C, Lambeth JD, et al. Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. <i>Circ Res<\/i> 2003; 93: 802\u2013805.","DOI":"10.1161\/01.RES.0000099504.30207.F5"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. O\u2019Connell TD, Swigart PM, Rodrigo MC, Ishizaka S, Joho S, Turnbull L, et al. \u03b1<sub>1<\/sub>-Adrenergic receptors prevent a maladaptive cardiac response to pressure overload. <i>J Clin Invest<\/i> 2006; 116: 1005\u20131015.","DOI":"10.1172\/JCI22811"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Kajstura J, Cigola E, Malhotra A, Li P, Cheng W, Meggs LG, et al. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. <i>J Mol Cell Cardiol<\/i> 1997; 29: 859\u2013870.","DOI":"10.1006\/jmcc.1996.0333"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/81\/12\/81_CJ-17-0394\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T02:57:57Z","timestamp":1750388277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/81\/12\/81_CJ-17-0394\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-17-0394","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}